Amid all the bad news at Pershing Square Capital Management – its long bet on Valeant Pharmaceuticals is down again today and its rare short on Herbalife is breaking into new yearly highs – there are signs of improvement. Considering the HSBC Hedge Weekly performance ranking for instance. Also see the top hedge fund letters Pershing Square is almost out off the 20 worst performers list William Ackman’s $3.9 billion activist fund, Pershing Square, has been on the list of 20 worst performers for nearly as long as its current drawdown. In 2015 the fund was the 11th worst performer,…
Dorset Energy Fund Up 50 Percent – Topping Hedge Fund Performance List
Mark Melin
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.